TAMARA THORN: Open Payments
NPI 1053606152 · MORAINE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37,479 in 171 payments from 11 companies in 2025. Trend: 2023 $15,144 · 2024 $15,814 · 2025 $37,479
Honoraria: $18,100Speaker / faculty: $12,357Travel & lodging: $3,473Food & beverage: $3,103Consulting: $330Education: $117
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 48 | $22,486 |
| Teva Pharmaceuticals USA, Inc. | 41 | $8,045 |
| Otsuka America Pharmaceutical, Inc. | 30 | $6,049 |
| Vanda Pharmaceuticals Inc. | 9 | $241 |
| Axsome Therapeutics, Inc. | 7 | $219 |
| Lundbeck LLC | 20 | $214 |
| E.R. Squibb & Sons, L.L.C. | 11 | $142 |
| Neos Therapeutics, LP | 2 | $33 |
| Alkermes, Inc. | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
Products named: Qelbree, AUSTEDO XR, REXULTI, UZEDY, Auvelity, FANAPT, COBENFY, HETLIOZ.
Industry payments across OH — which companies pay providers there.
